Present status of intrauterine treatment of hydrocephalus and its future.
At a time when the intrauterine diagnosis of hydrocephalus is common and pioneering efforts of antenatal therapy are evolving, an assessment of intrauterine treatment of this disorder becomes pertinent. Consequently, the current status of the intrauterine treatment of fetal hydrocephalus is presented. The new data from the International Fetal Surgery Registry at the University of Manitoba in Winnipeg are discussed. The technical problems of antenatal shunting, the clinical trials, and experimental treatment are assessed. The prognostication and possible new approaches in intrauterine treatment of hydrocephalus are presented as well as the new diagnostic and surgical techniques. The outcome of the antenatal diagnosis and treatment of fetal hydrocephalus is evaluated.
D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000000981:diagnostic imaging; D004027:Diencephalon / Q000473:pathology; D005260:Female; D005313:Fetal Death; D005315:Fetal Diseases / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy*; D005865:Gestational Age; D006801:Humans; D006849:Hydrocephalus / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy*; D008253:Macaca mulatta; D011247:Pregnancy; D011859:Radiography; D014222:Triamcinolone Acetonide
D014222:Triamcinolone Acetonide